Essbio Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Essbio.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Water Utilities earnings growth	11.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

We Think That There Are More Issues For Essbio (SNSE:ESSBIO-C) Than Just Sluggish Earnings

Sep 15

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Essbio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SNSE:ESSBIO-C - Analysts future estimates and past financials data (CLP Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	233,768	29,684	29,485	108,050	N/A
9/30/2023	235,755	25,526	33,728	109,236	N/A
6/30/2023	231,955	15,635	30,957	105,102	N/A
3/31/2023	225,154	6,926	31,705	100,170	N/A
12/31/2022	218,855	7,149	30,772	94,961	N/A
9/30/2022	209,537	6,942	29,139	87,647	N/A
6/30/2022	203,861	14,469	32,460	87,908	N/A
3/31/2022	197,455	20,267	27,641	81,660	N/A
12/31/2021	188,898	18,466	27,048	77,548	N/A
9/30/2021	183,492	20,347	24,195	74,217	N/A
6/30/2021	178,327	19,195	21,982	70,875	N/A
3/31/2021	175,472	20,127	20,844	68,509	N/A
12/31/2020	173,777	20,786	17,133	69,802	N/A
9/30/2020	171,483	21,107	23,501	79,813	N/A
6/30/2020	170,230	21,046	22,723	75,818	N/A
3/31/2020	169,935	20,094	26,767	78,149	N/A
12/31/2019	169,193	20,508	31,720	77,855	N/A
9/30/2019	168,477	21,139	33,404	73,913	N/A
6/30/2019	167,463	20,702	32,451	74,630	N/A
3/31/2019	163,758	20,694	32,149	75,230	N/A
12/31/2018	159,272	19,259	32,255	68,611	N/A
9/30/2018	156,185	17,720	30,637	60,638	N/A
6/30/2018	153,701	19,387	29,805	56,947	N/A
3/31/2018	151,904	22,260	27,757	50,551	N/A
12/31/2017	149,564	25,132	22,005	50,057	N/A
9/30/2017	149,298	27,874	N/A	46,367	N/A
6/30/2017	148,070	26,884	N/A	47,472	N/A
3/31/2017	146,712	23,866	N/A	45,691	N/A
12/31/2016	147,731	23,351	N/A	44,956	N/A
9/30/2016	141,451	27,218	N/A	46,721	N/A
6/30/2016	141,813	26,833	N/A	47,332	N/A
3/31/2016	142,406	26,295	N/A	51,453	N/A
12/31/2015	140,122	25,176	N/A	53,715	N/A
9/30/2015	144,233	16,276	N/A	45,469	N/A
6/30/2015	141,447	16,099	N/A	43,728	N/A
3/31/2015	137,367	13,264	N/A	37,992	N/A
12/31/2014	134,834	68,059	N/A	36,220	N/A
9/30/2014	131,934	71,759	N/A	44,109	N/A
6/30/2014	130,316	71,774	N/A	41,601	N/A
3/31/2014	127,730	75,169	N/A	40,558	N/A
12/31/2013	122,736	16,798	N/A	40,785	N/A
9/30/2013	120,960	7,617	N/A	42,020	N/A
6/30/2013	118,660	4,407	N/A	43,851	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ESSBIO-C's forecast earnings growth is above the savings rate (5.4%).

Earnings vs Market: Insufficient data to determine if ESSBIO-C's earnings are forecast to grow faster than the CL market

High Growth Earnings: Insufficient data to determine if ESSBIO-C's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ESSBIO-C's revenue is forecast to grow faster than the CL market.

High Growth Revenue: Insufficient data to determine if ESSBIO-C's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ESSBIO-C's Return on Equity is forecast to be high in 3 years time

Essbio Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Full year 2023 earnings released: EPS: CL$2.00 (vs CL$0.27 in FY 2022)

Upcoming dividend of CL$0.45 per share at 8.9% yield

Second quarter 2023 earnings released

Upcoming dividend of CL$0.27 per share at 2.3% yield

Third quarter 2022 earnings released

No independent directors

We Think That There Are More Issues For Essbio (SNSE:ESSBIO-C) Than Just Sluggish Earnings

Second quarter 2022 earnings released

First quarter 2022 earnings released

Upcoming dividend of CL$0.70 per share

No independent directors

Full year 2021 earnings: Revenues in line with analyst expectations

Third quarter 2021 earnings: Revenues in line with analyst expectations

Second quarter 2021 earnings released

Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?

First quarter 2021 earnings released

Upcoming dividend of CL$0.24 per share

A Look At The Intrinsic Value Of Essbio S.A. (SNSE:ESSBIO-C)

Full year 2020 earnings released

Should You Be Impressed By Essbio's (SNSE:ESSBIO-C) Returns on Capital?

Here's Why Essbio (SNSE:ESSBIO-C) Has A Meaningful Debt Burden

Should Essbio S.A. (SNSE:ESSBIO-C) Focus On Improving This Fundamental Metric?

Has Essbio (SNSE:ESSBIO-C) Got What It Takes To Become A Multi-Bagger?

Is Essbio (SNSE:ESSBIO-C) Using Too Much Debt?

First half earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies